Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Selah Genomics; Soft Landing Labs; Thermo Fisher Scientific; Agilent; Becton Dickinson; Quest; Rancho BioSciences; EnviroLogix; ABMGG

NEW YORK (GenomeWeb) – Selah Genomics, a wholly owned subsidiary of EKF Diagnostics, has inked an agreement with an unnamed US national sales organization to provide testing services for a new suite of assays focused on women's health. The organization has an established customer base of clinicians who use its panel of women's health tests, which will be run at Selah's CLIA-certified laboratory in Greenville, SC. The test menu is also being expanded to include the Roche cobas HPV Test. Financial and other terms of the agreement were not disclosed.

Specialized laboratory testing firm Soft Landing Labs is expanding its capabilities to include proteomic, metabolomic, and perhaps genomic testing with a focus on pain syndromes and psychiatric disorders. It initially plans to offer a CYP450 test to help clinicians choose optimal antidepressants for their patients. Soft Landing said it hopes to make the test available by the end of 2014. It also is collaborating with unnamed partners to develop biomarkers for other diseases, including attention deficit hyperactive disorder, it said.

Thermo Fisher Scientific's board approved a $.15 per share quarterly cash dividend payable on July 15 to shareholders of record on June 16.

Agilent Technologies announced a quarterly dividend of $.132 per share payable on July 23 to shareholders of record on July 1.

Becton Dickinson's board approved a $.545 per share quarterly dividend payable on June 30 to shareholders of record on June 9. The indicated annual dividend rate is $2.18 per share.

Quest Diagnostics said its board approved a quarterly cash dividend of $.33 per share payable on July 23 to shareholders of record on July 9.

Rancho BioSciences said it is now an affiliate member of the tranSMART Foundation and has donated 11 manually curated datasets to be used for testing and hackathons. The San Diego-based firm will work with the foundation to develop a new track called "Testathon" by donating resources for every release cycle so that the tranSMART platform can be tested and bugs can be reported to the development team before the final product is released. The non-profit foundation provides an open-source knowledge management platform for the sharing of pre-competitive research data by scientists.

The AOAC Research Institute has certified EnviroLogix's DNAble Detection Assay for Salmonella as a Performance Tested Method in the categories of primary production samples, environmental samples for food or feed production, and pet food and animal feed. EnviroLogix's DNAble technology delivers rapid, accurate, and precise test results compared to traditional molecular test techniques, the company said.

The American Board of Medical Genetics has changed its name to the American Board of Medical Genetics and Genomics. ABMGG certifies genetic specialists and accredits laboratory training programs in human genetics.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.